Squarepoint’s AtriCure ATRC Stock Holding History

Squarepoint’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$557K	Buy	+9,913	New	+$447K	﹤0.01%	3289
2026 Q1	–	Sell	-85,803	Closed	-$3.39M	–	4255
2025 Q4	$3.39M	Sell	85,803 -88,886	-51%	-$3.26M	﹤0.01%	1706
2025 Q3	$6.16M	Sell	174,689 -12,276	-7%	-$423K	0.01%	1337
2025 Q2	$6.13M	Buy	186,965 +73,468	+65%	+$2.39M	0.01%	1331
2025 Q1	$3.66M	Buy	113,497 +58,025	+105%	+$2.15M	﹤0.01%	1630
2024 Q4	$1.7M	Sell	55,472 -101,207	-65%	-$3.25M	﹤0.01%	2564
2024 Q3	$4.39M	Sell	156,679 -70,197	-31%	-$1.73M	0.01%	1493
2024 Q2	$5.17M	Buy	226,876 +96,501	+74%	+$2.23M	0.01%	1360
2024 Q1	$3.97M	Sell	130,375 -29,779	-19%	-$998K	0.01%	1619
2023 Q4	$5.72M	Buy	160,154 +86,012	+116%	+$3.2M	0.01%	1309
2023 Q3	$3.25M	Buy	74,142 +39,077	+111%	+$1.91M	0.01%	1461
2023 Q2	$1.73M	Buy	35,065 +6,565	+23%	+$303K	0.01%	1762
2023 Q1	$1.18M	Buy	+28,500	New	+$1.18M	﹤0.01%	1783
2022 Q3	–	Sell	-31,464	Closed	-$1.29M	–	2982
2022 Q2	$1.29M	Buy	31,464 +13,746	+78%	+$651K	0.01%	1456
2022 Q1	$1.16M	Buy	17,718 +14,284	+416%	+$926K	0.01%	1493
2021 Q4	$239K	Sell	3,434 -16,543	-83%	-$1.2M	﹤0.01%	2591
2021 Q3	$1.39M	Buy	19,977 +16,391	+457%	+$1.26M	﹤0.01%	1382
2021 Q2	$284K	Buy	+3,586	New	+$261K	﹤0.01%	2573
2021 Q1	–	Sell	-26,622	Closed	-$1.48M	–	3093
2020 Q4	$1.48M	Buy	+26,622	New	+$1.15M	0.01%	1100
2020 Q2	–	Sell	-11,889	Closed	-$399K	–	2217
2020 Q1	$399K	Sell	11,889 -10,555	-47%	-$379K	0.01%	1157
2019 Q4	$730K	Sell	22,444 -27,881	-55%	-$793K	﹤0.01%	1533
2019 Q3	$1.26M	Sell	50,325 -44,489	-47%	-$1.27M	0.01%	1073
2019 Q2	$2.83M	Buy	94,814 +49,173	+108%	+$1.44M	0.03%	662
2019 Q1	$1.22M	Buy	45,641 +36,152	+381%	+$1.1M	0.01%	997
2018 Q4	$290K	Buy	+9,489	New	+$296K	﹤0.01%	1524
2017 Q4	–	Sell	-15,844	Closed	-$354K	–	2071
2017 Q3	$354K	Buy	+15,844	New	+$358K	0.01%	1105

Other funds holding ATRC

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Champlain Investment Partners Burlington, Vermont $2.9B AUM 23.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Squarepoint's ATRC Position: Q3 2026 in Review

Squarepoint opened a new position in AtriCure (ATRC) in Q3 2026: 9,913 shares worth $557K. The stake represents ﹤0.01% of the portfolio and ranks #3289 among its holdings. This is a return to the name: Squarepoint previously reported a position in ATRC as recently as Q4 2025.

Squarepoint first reported a position in ATRC in Q3 2017 and has held it in 26 quarters since. The position peaked at $6.16M in Q3 2025. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

Squarepoint held 9,913 shares of AtriCure worth $557K as of Q3 2026.
AtriCure was a new Squarepoint position in Q3 2026.
AtriCure made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3289 holding.
Squarepoint first reported a position in AtriCure in Q3 2017 and has held it in 26 quarters since.
Squarepoint's AtriCure position peaked at $6.16M in Q3 2025.
183 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.